Abstract
Arterial hypertension is a major chronic condition and a leading cardiovascular risk factor, responsible for significant morbidity and mortality. Despite the availability of effective antihypertensive treatments, blood pressure control remains insufficient. This study aims to assess the prevalence of blood pressure control in a hypertensive population followed in Béchar, and to identify the predictive factors associated with this control. It is a longitudinal descriptive study that included 382 hypertensive patients followed in the cardiology department of the military hospital of Béchar between November 2021 and June 2023. Blood pressure control was assessed by home blood pressure monitoring , defined according to European guidelines as an average systolic blood pressure (SBP) <135 mmHg and an average diastolic blood pressure (DBP) <85 mmHg. A multivariate logistic regression analysis identified the factors associated with blood pressure control. Results: The mean age was 57.5 ± 14 years, with 44% men, and 50% showed blood pressure imbalance according to SMP. The average home SBP was 132.3 ± 11.7 mmHg, and the average DBP was 82.4 ± 9.7 mmHg. Factors significantly associated with poor blood pressure control included a high body mass index, high office SBP, left ventricular hypertrophy, and lack or insufficient pharmacological treatment. This study highlights the importance of assessing blood pressure control through home blood pressure monitoring in hypertensive patients. It identifies key factors, such as obesity and left ventricular hypertrophy, that influence blood pressure control. More targeted management and regular follow-up are essential to improve hypertension control and reduce associated risks.
References
Poulter NR, Prabhakaran D, Caulfield M. Hypertension. Lancet Lond Engl. 22 août 2015;386(9995):801‑12.
Pereira M, Lunet N, Azevedo A, Barros H. Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens. mai 2009;27(5):963‑75.
Bliziotis IA, Destounis A, Stergiou GS. Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens. juill 2012;30(7):1289‑99.
Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies. J Hypertens. mars 2012;30(3):449‑56.
McManus RJ, Mant J, Haque MS, Bray EP, Bryan S, Greenfield SM, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 27 août 2014;312(8):799‑808.
Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 1 sept 2018;39(33):3021‑104.
Stergiou GS, Palatini P, Parati G, O’Brien E, Januszewicz A, Lurbe E, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 1 juill 2021;39(7):1293‑302.
Ambaw AD, Alemie GA, W/Yohannes SM, Mengesha ZB. Adherence to antihypertensive treatment and associated factors among patients on follow up at University of Gondar Hospital, Northwest Ethiopia. BMC Public Health. 10 avr 2012;12:282.
Adebolu FA, Naidoo M. Blood pressure control amongst patients living with hypertension presenting to an urban district hospital outpatient clinic in Kwazulu-Natal. Afr J Prim Health Care Fam Med. 28 juill 2014;6(1):E1-6.
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 1 janv 2013;127(1):e6‑245.
Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. janv 2004;22(1):11‑9.
Chow CK, Teo KK, Rangarajan S, Islam S, Gupta R, Avezum A, et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA. 4 sept 2013;310(9):959‑68.
Nejjari C, Arharbi M, Chentir MT, Boujnah R, Kemmou O, Megdiche H, et al. Epidemiological Trial of Hypertension in North Africa (ETHNA): an international multicentre study in Algeria, Morocco and Tunisia. J Hypertens. janv 2013;31(1):49‑62.
Nibouche D, Belhamidi S, Amara T, Larbi K, Ziani A. Étude du niveau de pression artérielle en consultation chez l’hypertendu algérien traité (PACT II). Ann Cardiol Angéiologie. 1 oct 2023;72(4):101631.
Kettani FZ, Dragomir A, Côté R, Roy L, Bérard A, Blais L, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke. janv 2009;40(1):213‑20.
Perreault S, Dragomir A, White M, Lalonde L, Blais L, Bérard A. Better adherence to antihypertensive agents and risk reduction of chronic heart failure. J Intern Med. août 2009;266(2):207‑18.
Geldsetzer P, Manne-Goehler J, Marcus ME, Ebert C, Zhumadilov Z, Wesseh CS, et al. The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1·1 million adults. Lancet Lond Engl. 24 août 2019;394(10199):652‑62.
Gupta R, Gaur K, S Ram CV. Emerging trends in hypertension epidemiology in India. J Hum Hypertens. août 2019;33(8):575‑87.
Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet Lond Engl. 9 déc 2017;390(10112):2549‑58.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2024 Medical Focus Journal